Stay updated on ARO-APOC3 in Dyslipidemia Clinical Trial

Sign up to get notified when there's something new on the ARO-APOC3 in Dyslipidemia Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ARO-APOC3 in Dyslipidemia Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Revision header updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-12T03:23:59.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.4.2, and the previous items 'Notice Because of a lapse in government funding...' and 'Revision: v3.4.1' have been removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-02-11T14:36:36.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    A government funding lapse notice is now displayed at the top of the page. The site revision was updated from v3.4.0 to v3.4.1.
    Difference
    0.3%
    Check dated 2026-02-04T10:39:51.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Added Show glossary and updated metadata to include 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and 'Revision: v3.4.0'. Replaced the previous indicators 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4'.
    Difference
    0.2%
    Check dated 2026-01-28T06:33:09.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Revision updated from v3.3.3 to v3.3.4 on the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-14T03:09:00.000Z thumbnail image
  8. Check
    83 days ago
    Change Detected
    Summary
    Added a broad list of trial locations across the United States, Australia, Canada, and New Zealand, and updated the study status to Completed. These changes reflect the open-label extension and expanded site participation.
    Difference
    2%
    Check dated 2025-12-23T20:56:33.000Z thumbnail image

Stay in the know with updates to ARO-APOC3 in Dyslipidemia Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ARO-APOC3 in Dyslipidemia Clinical Trial page.